CNXU — CONEXEU SCIENCES
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Oct 2026 | -0.11 | — | -0.11 | -0.11 | 1 | — |
| Jan 2027 | -0.12 | — | -0.12 | -0.12 | 1 | — |
| Apr 2027 | -0.13 | — | -0.13 | -0.13 | 1 | — |
| Jul 2027 | -0.14 | — | -0.14 | -0.14 | 1 | — |
| Oct 2027 | -0.15 | — | -0.15 | -0.15 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Oct 2026 | -0.40 | — | -0.40 | -0.40 | 1 | — |
| Oct 2027 | -0.53 | — | -0.53 | -0.53 | 1 | — |
| Oct 2028 | 1.02 | 2.3× | 1.02 | 1.02 | 1 | — |
| Oct 2029 | 1.70 | 1.4× | 1.70 | 1.70 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 32 SEC-registered investment managers reported holding CNXU (CONEXEU SCIENCES) in their latest 13F filings, with a combined reported value of $2.82M across 788.93K shares. That is +227.7% by share count (+46.04K shares) versus the previous quarter, while reported value moved +8.1%. Ownership is concentrated: the five largest holders account for 84.5% of reported value and the top ten for 96.3%.
Compared with the prior quarter, 26 opened new positions, 3 added to existing stakes, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of CONEXEU SCIENCES (CNXU) include VANGUARD CAPITAL MANAGEMENT LLC, Geode Capital Management, Renaissance Technologies, ranked by reported 13F value among the 34 institutional holders on this page.
CNXU is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 32 | 788.93K | $2.82M | +227.7% |
| Q2 2026 | 8 | 25.84K | $282.50K | — |
Over the 2 quarters shown, institutional share counts increased 2953% in aggregate (Q2 2026 → Q3 2026).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 257.88K | $920.62K | 0.00% | New | |
| 150.51K | $537.33K | 0.00% | New | |
| 114.44K | $408.54K | 0.00% | New | |
| 92.56K | $330.46K | 0.00% | New | |
| 51.70K | $184.55K | 0.00% | Add | |
| 32.69K | $116.71K | 0.00% | New | |
| 23.20K | $82.82K | 0.00% | New | |
| 13.58K | $48.48K | 0.00% | New | |
| 12.81K | $45.74K | 0.01% | New | |
| 10.58K | $39.15K | 0.00% | Add | |
| 10.00K | $35.70K | 0.00% | New | |
| 6.73K | $24.01K | 0.00% | New | |
| 2.60K | $9.28K | 0.00% | New | |
| 2.10K | $8.17K | 0.00% | Add | |
| 1.11K | $4.14K | 0.00% | New | |
| 1.04K | $3.72K | 0.00% | New | |
| 1.00K | $3.57K | 0.00% | New | |
| 1.00K | $3.57K | 0.00% | Hold | |
| 736 | $3.00K | 0.00% | Reduce | |
| 716 | $2.56K | 0.00% | New | |
| 325 | $1.16K | 0.00% | New | |
| 289 | $1.03K | 0.00% | New | |
| 281 | $1.00K | 0.00% | New | |
| 200 | $714 | 0.00% | New | |
| 200 | $714 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.26K | $133.92K | 0.00% | New | |
| 5.87K | $64.11K | 0.00% | New | |
| 5.22K | $56.99K | 0.00% | New | |
| 1.00K | $10.92K | 0.00% | New | |
| 887 | $10.00K | 0.00% | New | |
| 400 | $4.37K | 0.00% | New | |
| 100 | $1.10K | 0.00% | New | |
| 100 | $1.09K | 0.00% | New |
New Positions (Q3 2026)
- VANGUARD CAPITAL MANAGEMENT LLC 257.88K sh · $920.62K
- Geode Capital Management 150.51K sh · $537.33K
- Renaissance Technologies 114.44K sh · $408.54K
- VANGUARD FIDUCIARY TRUST CO 92.56K sh · $330.46K
- Northern Trust Corp 32.69K sh · $116.71K
- STATE STREET CORP 23.20K sh · $82.82K
- Citadel Advisors 13.58K sh · $48.48K
- AXQ CAPITAL, LP 12.81K sh · $45.74K
- Jefferies Financial Group Inc. 10.00K sh · $35.70K
- Vanguard Global Advisers, LLC 6.73K sh · $24.01K
- Wells Fargo & Co 2.60K sh · $9.28K
- JPMorgan Chase & Co 1.11K sh · $4.14K
Fully Exited (vs previous quarter)
- Citigroup Inc sold 5.22K sh · $56.99K
- Integrated Wealth Concepts LLC sold 400 sh · $4.37K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 257.88K | — |
| Geode Capital Management | 150.51K | — |
| Renaissance Technologies | 114.44K | — |
| VANGUARD FIDUCIARY TRUST CO | 92.56K | — |
| UBS Group AG | 51.70K | 12.26K |
| Northern Trust Corp | 32.69K | — |
| STATE STREET CORP | 23.20K | — |
| Citadel Advisors | 13.58K | — |
| AXQ CAPITAL, LP | 12.81K | — |
| OSAIC HOLDINGS, INC. | 10.58K | 100 |
| Jefferies Financial Group Inc. | 10.00K | — |
| Vanguard Global Advisers, LLC | 6.73K | — |
| Wells Fargo & Co | 2.60K | — |
| JONES FINANCIAL COMPANIES LLLP | 2.10K | 100 |
| JPMorgan Chase & Co | 1.11K | — |
| Tower Research Capital LLC (TRC) | 1.04K | — |
| HOLLENCREST CAPITAL MANAGEMENT | 1.00K | 1.00K |
| Paladin Partners, LLC | 1.00K | — |
| ROYAL BANK OF CANADA | 736 | 887 |
| BlackRock Inc | 716 | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CNXU?
As of 2026-Q3, 32 institutional funds reported holding CNXU (CONEXEU SCIENCES) in SEC 13F filings, with a combined reported value of $2.82M.
How many shares of CNXU do institutions own?
13F filers reported 788.93K shares of CNXU, worth $2.82M in aggregate at the end of 2026-Q3.
Is institutional ownership of CNXU rising or falling?
Share counts moved +227.7% versus the prior quarter — accumulation.
Who are the top institutional holders of CNXU?
The largest 13F holders are VANGUARD CAPITAL MANAGEMENT LLC, Geode Capital Management, Renaissance Technologies, VANGUARD FIDUCIARY TRUST CO, UBS Group AG; the top 25 are ranked at the top of this page.
Who are the major shareholders of CONEXEU SCIENCES?
The major shareholders of CONEXEU SCIENCES (CNXU) by reported 13F value are VANGUARD CAPITAL MANAGEMENT LLC, Geode Capital Management, Renaissance Technologies, VANGUARD FIDUCIARY TRUST CO, UBS Group AG, among 34 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.